“…More recently, through isothermal titration calorimetry and protein crystal structure analysis, we have demonstrated the increased binding strength of benzene and ethylbenzene BN-analogues in the polar binding pocket of T4 lysozyme mutants through a hydrogen bonding interaction unavailable in the carbonaceous compounds 6. As a pharmacophore in medicinal chemistry, BN analogues of naphthalene-containing biologically active compounds have been studied through ADMET (absorption, distribution, metabolism, excretion, toxicity) and biological activity profiling, both in vivo and in vitro 8,9. We have shown, also through ADMET profiling, that the 1,2-azaborine analogues of biologically active compounds can increase the bioavailability of the drug without significantly altering the activity of the all-carbon substrate 10.…”